表紙
市場調查報告書
商品編碼
1017953

吡啶的全球市場 (2021年∼2028年)

Global Pyridine Market - 2021-2028

出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

在藥品、農藥和食品添加劑需求增加的背景下,預計全球吡啶市場將繼續擴大。另一方面,政府的使用限制可能會阻礙市場增長。按類型劃分,吡啶N-氧化物的份額最高,而β-甲基吡啶增長迅速。就最終用戶而言,藥品擁有最高的市場份額。按地區劃分,亞太地區是最大的市場。

本報告提供全球吡啶的市場相關分析,提供市場規模趨勢預測,及各類型·各終端用戶·各地區的詳細趨勢,主要的推動及阻礙市場要素,主要企業的簡介等相關調查。

目錄

第1章 吡啶市場:分析方法·範圍

第2章 吡啶市場:主要趨勢和動靜

第3章 吡啶市場:摘要整理

第4章 吡啶市場:市場動態

  • 對市場的影響要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 吡啶市場:產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 法規分析
  • 專利分析

第6章 吡啶市場:新型冠狀病毒感染疾病 (COVID-19)的分析

  • COVID-19對市場的影響分析
    • "COVID-19前" /過去的市場方案
    • "COVID-19中" /目前市場方案
    • "COVID-19後" /未來市場方案
  • COVID-19流行中的價格趨勢
  • 需求與供給的變動階段
  • 政府在COVID-19疫情下的市場相關措施
  • 各製造公司的策略展開情形
  • 結論

第7章 吡啶市場:各類型

  • 簡介
  • 市場規模的分析以及與前一年同期相比成長率 (YoY):各類型
  • 市場向心力指數:各類型
  • 吡啶N-oxide
    • 簡介
    • 市場規模·與前一年同期相比成長率 (YoY)
  • ALPHA PICOLINE
  • BETA PICOLINE
  • GAMMA PICOLINE
  • 2-METHYL-5-ETHYLPYRIDINE (MEP)
  • 其他

第8章 吡啶市場:各終端用戶

  • 簡介
  • 市場規模的分析以及與前一年同期相比成長率 (YoY):各終端用戶
  • 市場向心力指數:各終端用戶
  • 農藥
  • 醫藥品
  • 化學產品
  • 食品
  • 其他

第9章 吡啶市場:各地區

  • 簡介
    • 市場規模和與前一年同期相比成長率 (YoY):各地區
    • 市場向心力指數:各地區
  • 北美
    • 簡介
    • 域內市場固有趨勢
    • 市場規模·與前一年同期相比成長率 (YoY):各類型
    • 市場規模·與前一年同期相比成長率 (YoY):各終端用戶
    • 市場規模·與前一年同期相比成長率 (YoY):各國
  • 歐洲
  • 南美
  • 亞太地區
  • 中東·非洲

第10章 吡啶市場:競爭情形

  • 競爭方案
  • 企業策略分析
  • 組合的種類:比較分析
  • 市場定位/佔有率分析
  • 企業合併·收購 (M&A)的分析

第11章 企業簡介

  • RED SUN GROUP
    • 企業概要
    • 產品的種類/組合/概要
    • 近幾年趨勢
    • 主要的財務指標
  • JUBILANT LIFE SCIENCES LIMITED
  • KOEI CHEMICAL CO. LTD
  • LONZA GROUP LTD
  • MITSUBISHI CHEMICAL CORPORATION
  • NOVASYN ORGANICS PVT. LTD
  • RESONANCE SPECIALTIES LIMITED
  • VERTELLUS SPECIALTIES INC.
  • SHANDONG LUBA CHEMICAL CO. LTD
  • WEIFANG SUNWIN CHEMICALS CO. LTD

第12章 全球吡啶市場:重要考察

第13章 關於DataM Intelligence

目錄
Product Code: DMPC2307

Market Overview:

Pyridine is a combustible, poisonous, and soluble liquid base with a distinct, pungent odour. It's frequently thought to be the parent compound of a number of naturally occurring organic compounds. As a predecessor to agrochemicals and medicines, it is the favoured choice. Pyridine was first recovered from coal tar or as a by-product of coal gasification. The global pyridine market valued USD XX million in 2020 and is estimated to reach USD XX million by 2028, growing at a CAGR of XX%

Market Dynamics:

During the projected period, the market is anticipated to be driven by growing demand for pyridine and its derivatives in pharmaceuticals and agrochemicals applications due to numerous chemical functionalities. Pyridine was once exclusively utilised as a solvent in chemicals, adhesives, and medicines, but pyridine derivatives are now being employed as a starting material for agrochemicals, pharmaceuticals, food flavouring additives, and other products. The substance is also authorised by the FDA for use as a low-volume addition in the food sector to impart bitter taste. It's also used as an antifreeze combination to prevent alcohol from becoming denatured. The expansion of the pyridine market would be aided by a rise in applications in the food industry. The worldwide pyridine business is expanding due to advancements in biocatalyst processes, rising demand for synthetic pyridines, and the increasing use of pyridine in pesticides and herbicides. Companies are conducting extensive research to improve the use of pyridine in agrochemicals such as fungicides, insecticides, and herbicides.

The many rules and regulations established by various government agencies, however, are one of the key constraints in the global market for Pyridine. If breathed, ingested, or absorbed via the skin, pyridine is toxic. Some industrial operations emit trace quantities of pyridine into the environment. According to a study by the U.S National Institute for Occupational Safety and Health, about 43,000 Americans work in contact with pyridines, which is harmful.

Covid 19 Analysis:

Pyridine prices have risen dramatically in 2019 due to increased demand for pesticides and herbicides in the agriculture industry for various crop rotation methods. Furthermore, the pandemic of COVID-19 has increased demand for Pyridine as an active initiator in medication manufacturing. Despite its strong demand, Pyridine prices have remained low due to decreased costs of feedstock Acetaldehyde and a historic drop in crude oil value. Pyridine costs have also dropped considerably in Europe and North America.

Market Segmentation:

By Type, the Pyridine market is segmented into Pyridine N-Oxide, Alpha Picoline, Beta Picoline, Gamma Picoline, 2-Methyl-5-Ethylpyridine (MEP) and others. Pyridine N-oxide holds a significant share in the market. Alpha picoline has extensive applications in manufacturing vinyl pyridine latex, which is used as an intermediate in various industries like agrochemicals, pharmaceuticals, dye, and photo industries. Beta Picoline is used to produce Vitamin B3. The beta picoline sector is expected to grow at a fastest CAGR throughout the forecast period in terms of volume. This is mostly due to growing niacin (Vitamin B3) demand in emerging countries such as Asia-pacific and the Middle East and Africa.

By End Users, the Global Pyridine market is bifurcated into Pharmaceuticals, Agrochemicals, Chemicals, Food, and others. The pharmaceuticals segment is majorly responsible for most of the share in the pyridine market. In the pharmaceutical industry, pyridine forms the nucleus of over 7000 existing drugs. Pyridine is used as an antimicrobial, antioxidant, antiviral, antidiabetic, anticancer, antimalarial, anti-inflammatory etc. For instance, Cu(II) metal complexes with 2-[N-(a-picolyl)-amino] Schiff base -benzophenone on pyridine, especially brominated derivatives, have the maximum cytotoxicity and anticancer activity. Also, antidiabetic properties are seen in pyridine derivatives including thiazolidinones. The findings demonstrate that some of these compounds have highly effective anti-diabetic properties, while just a few of them have significant anti-diabetic properties, and these discoveries might lead to the creation of a new class of anti-diabetic medicines in the future.

Geographical Penetration:

By Geography, the global pyridine market is segmented into North America, Asia-Pacific, Europe, South America and the Middle East and Africa. Asia-Pacific region is set to dominate the global Pyridine market owing to the expansion of numerous end-use sectors, including agriculture, food and beverage, and the chemical industry, to name a few. Due to a growing customer base and favourable government laws, pyridine demand is projected to rise in Asia Pacific nations such as Bangladesh, China, Japan, India, South Korea, Vietnam, and Malaysia. Also the increasing availability of raw materials, land, labour are the crucial factors for the dominance of pyridine market in the Asia-pacific region. Europe and North America are set to follow next in terms of the global pyridine market. Over the forecast period, Europe is expected to have a significant increase in the pyridine market due to a strong customer base for a variety of end use sectors, as well as increased expenditures to rejuvenate the food and beverage industry. In North America, the growth in chemicals and Pharmaceuticals is expected to be the driving force for the pyridine Market.

Competitive Landscape:

Key players adopt strategies such as mergers and acquisitions, partnerships, and regional expansion to stand out as strong competitors in the market. New product launches and increasing R&D are other ways the leading players improve their market presence. Some of the prominent players operating in the global pyridine market are Jubilant Life Sciences Ltd., KOEI CHEMICAL CO., LTD., Lasons, Vertellus Holdings LLC, The Dow Chemical Company.

Lonza, one of the key players, announces a new Research and Development Collaborative Innovation center in Israel. This new center is set to accelerate R&D projects from across Lonza's Pharma & Biotech segment and tap into potentially transformative biological and manufacturing capabilities.

Vertellus Holdings LLC has been acquired by Pritzker Private Capital.

In 2020, during the pandemic, KOEI Chemical started producing pyrrole, an important, raw material for Remdesivir, which is a therapeutic drug for Covid 19

KOEI Chemical Co Ltd.

Overview:

Koei was founded in June, 1917. Their headquarters is located in Tokyo, Japan. It was in 1964 when they started to produce pyridine bases.

Product Portfolio:

Pyridines

Picolines

Lutidines

Cyanopyrazine

Key Developments:

In Financial year 2019, the company made 18.528 billion yen in sales

In 2020, Koei decided to expand the production capacity of multi-purpose facilities at Chiba plant in Chiba, Japan.

Why Purchase the Report?

Visualize the Global Pyridine Market's composition across each indication, in terms of Type, and End User options, highlighting the critical commercial assets and players.

Identify commercial opportunities in the Global Pyridine Market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of the Global Pyridine Market - level 4/5 segmentation.

A PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Type mapping in excel for the key Services of all major market players.

Extensive Technical and Safety Datasheets of major market players.

Target Audience:

Equipment Suppliers/ Buyers

Type Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Table of Contents

1. PYRIDINE MARKET -SCOPE AND METHODOLOGY

  • 1.1. RESEARCH METHODOLOGY
  • 1.2. SCOPE OF THE MARKET

2. PYRIDINE MARKET -KEY TRENDS AND DEVELOPMENTS

  • 2.1. KEY TRENDS AND DEVELOPMENTS

3. PYRIDINE MARKET - EXECUTIVE SUMMARY

  • 3.1. MARKET SNIPPET BY TYPE
  • 3.2. MARKET SNIPPET BY END USER
  • 3.3. MARKET SNIPPET BY REGION
  • 3.4. DATAM CLO SCENARIO

4. PYRIDINE MARKET-MARKET DYNAMICS

  • 4.1. MARKET IMPACTING FACTORS
  • 4.2. DRIVERS
    • 4.2.1. GROWTH OF PHARMACEUTICALS AND AGROCHEMICALS
    • 4.2.2. DRIVER 2
  • 4.3. RESTRAINTS
    • 4.3.1. VARIOUS HEALTH-CONCERNING ISSUES.
    • 4.3.2. RESTRAINT 2
  • 4.4. OPPORTUNITY
  • 4.5. IMPACT ANALYSIS

5. PYRIDINE MARKET - INDUSTRY ANALYSIS

  • 5.1. PORTER'S FIVE FORCES ANALYSIS
  • 5.2. SUPPLY CHAIN ANALYSIS
  • 5.3. PRICING ANALYSIS
  • 5.4. REGULATORY ANALYSIS
  • 5.5. PATENT ANALYSIS

6. Pyridine Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. PYRIDINE MARKET - BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. MARKET SIZE ANALYSIS, AND Y-O-Y GROWTH ANALYSIS (%), BY TYPE SEGMENT
  • 7.3. MARKET ATTRACTIVENESS INDEX, BY TYPE SEGMENT
  • 7.4. PYRIDINE N-OXIDE
    • 7.4.1. INTRODUCTION
    • 7.4.2. MARKET SIZE ANALYSIS AND Y-O-Y GROWTH ANALYSIS (%)
  • 7.5. ALPHA PICOLINE
  • 7.6. BETA PICOLINE
  • 7.7. GAMMA PICOLINE
  • 7.8. 2-METHYL-5-ETHYLPYRIDINE (MEP)
  • 7.9. OTHERS

8. PYRIDINE MARKET - BY END USER

  • 8.1. INTRODUCTION
  • 8.2. MARKET SIZE ANALYSIS, AND Y-O-Y GROWTH ANALYSIS (%), BY END USER
  • 8.3. MARKET ATTRACTIVENESS INDEX, BY END USER
  • 8.4. AGROCHEMICALS
    • 8.4.1. INTRODUCTION
    • 8.4.2. MARKET SIZE ANALYSIS, Y-O-Y GROWTH ANALYSIS (%)
  • 8.5. PHARMACEUTICALS
  • 8.6. CHEMICALS
  • 8.7. FOOD
  • 8.8. OTHERS

9. PYRIDINE MARKET - BY REGION

  • 9.1. INTRODUCTION
  • 9.2. MARKET SIZE ANALYSIS, AND Y-O-Y GROWTH ANALYSIS (%), BY REGION
  • 9.3. MARKET ATTRACTIVENESS INDEX, BY REGION
  • 9.4. NORTH AMERICA
    • 9.4.1. INTRODUCTION
    • 9.4.2. KEY REGION-SPECIFIC DYNAMICS
    • 9.4.3. MARKET SIZE ANALYSIS, AND Y-O-Y GROWTH ANALYSIS (%), BY TYPE
    • 9.4.4. MARKET SIZE ANALYSIS, AND Y-O-Y GROWTH ANALYSIS (%), BY END USER
    • 9.4.5. MARKET SIZE ANALYSIS, AND Y-O-Y GROWTH ANALYSIS (%), BY COUNTRIES
      • 9.4.5.1. THE U.S.
      • 9.4.5.2. CANADA
      • 9.4.5.3. MEXICO
  • 9.5. EUROPE
    • 9.5.1. INTRODUCTION
    • 9.5.2. KEY REGION-SPECIFIC DYNAMICS
    • 9.5.3. MARKET SIZE ANALYSIS, AND Y-O-Y GROWTH ANALYSIS (%), BY TYPE
    • 9.5.4. MARKET SIZE ANALYSIS, AND Y-O-Y GROWTH ANALYSIS (%), BY END USER
    • 9.5.5. MARKET SIZE ANALYSIS, AND Y-O-Y GROWTH ANALYSIS (%), BY COUNTRIES
      • 9.5.5.1. GERMANY
      • 9.5.5.2. THE U.K.
      • 9.5.5.3. FRANCE
      • 9.5.5.4. ITALY
      • 9.5.5.5. SPAIN
      • 9.5.5.6. REST OF EUROPE
  • 9.6. SOUTH AMERICA
    • 9.6.1. INTRODUCTION
    • 9.6.2. KEY REGION-SPECIFIC DYNAMICS
    • 9.6.3. MARKET SIZE ANALYSIS, AND Y-O-Y GROWTH ANALYSIS (%), BY TYPE
    • 9.6.4. MARKET SIZE ANALYSIS, AND Y-O-Y GROWTH ANALYSIS (%), BY END USER
    • 9.6.5. MARKET SIZE ANALYSIS, AND Y-O-Y GROWTH ANALYSIS (%), BY COUNTRIES
      • 9.6.5.1. BRAZIL
      • 9.6.5.2. ARGENTINA
      • 9.6.5.3. REST OF SOUTH AMERICA
  • 9.7. ASIA PACIFIC
    • 9.7.1. INTRODUCTION
    • 9.7.2. KEY REGION-SPECIFIC DYNAMICS
    • 9.7.3. MARKET SIZE ANALYSIS, AND Y-O-Y GROWTH ANALYSIS (%), BY TYPE
    • 9.7.4. MARKET SIZE ANALYSIS, AND Y-O-Y GROWTH ANALYSIS (%), BY END USER
    • 9.7.5. MARKET SIZE ANALYSIS, AND Y-O-Y GROWTH ANALYSIS (%), BY COUNTRIES
      • 9.7.5.1. CHINA
      • 9.7.5.2. INDIA
      • 9.7.5.3. JAPAN
      • 9.7.5.4. AUSTRALIA
      • 9.7.5.5. REST OF ASIA PACIFIC
  • 9.8. THE MIDDLE EAST AND AFRICA
    • 9.8.1. INTRODUCTION
    • 9.8.2. KEY REGION-SPECIFIC DYNAMICS
    • 9.8.3. MARKET SIZE ANALYSIS, AND Y-O-Y GROWTH ANALYSIS (%), BY TYPE
    • 9.8.4. MARKET SIZE ANALYSIS, AND Y-O-Y GROWTH ANALYSIS (%), BY END USER

10. PYRIDINE MARKET - COMPETITIVE LANDSCAPE

  • 10.1. COMPETITIVE SCENARIO
  • 10.2. COMPETITOR STRATEGY ANALYSIS
  • 10.3. COMPARATIVE TYPE PORTFOLIO ANALYSIS
  • 10.4. MARKET POSITIONING/SHARE ANALYSIS
  • 10.5. MERGERS AND ACQUISITIONS ANALYSIS

11. COMPANY PROFILES

  • 11.1. RED SUN GROUP
    • 11.1.1. COMPANY OVERVIEW
    • 11.1.2. TYPE PORTFOLIO AND DESCRIPTION
    • 11.1.3. KEY HIGHLIGHTS
    • 11.1.4. FINANCIAL OVERVIEW
  • 11.2. JUBILANT LIFE SCIENCES LIMITED
  • 11.3. KOEI CHEMICAL CO. LTD
  • 11.4. LONZA GROUP LTD
  • 11.5. MITSUBISHI CHEMICAL CORPORATION
  • 11.6. NOVASYN ORGANICS PVT. LTD
  • 11.7. RESONANCE SPECIALTIES LIMITED
  • 11.8. VERTELLUS SPECIALTIES INC.
  • 11.9. SHANDONG LUBA CHEMICAL CO. LTD
  • 11.10. WEIFANG SUNWIN CHEMICALS CO. LTD

12. PYRIDINE MARKET - PREMIUM INSIGHTS

13. PYRIDINE MARKET - DATAM

  • 13.1. APPENDIX
  • 13.2. ABOUT US AND SERVICES
  • 13.3. CONTACT US